223 related articles for article (PubMed ID: 37285835)
21. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.
Zhang C; Zheng JH; Lin ZH; Lv HY; Ye ZM; Chen YP; Zhang XY
Aging (Albany NY); 2020 Feb; 12(4):3486-3501. PubMed ID: 32039832
[TBL] [Abstract][Full Text] [Related]
22. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
[TBL] [Abstract][Full Text] [Related]
23. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
[TBL] [Abstract][Full Text] [Related]
24. A tumor microenvironment-based prognostic index for osteosarcoma.
Wu C; Gong S; Duan Y; Deng C; Kallendrusch S; Berninghausen L; Osterhoff G; Schopow N
J Biomed Sci; 2023 Apr; 30(1):23. PubMed ID: 37055822
[TBL] [Abstract][Full Text] [Related]
25. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
Liu R; Hu Y; Liu T; Wang Y
BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
[TBL] [Abstract][Full Text] [Related]
26. Construction of a cuproptosis-related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients.
Ni S; Hong J; Li W; Ye M; Li J
Cancer Med; 2023 Feb; 12(4):5009-5024. PubMed ID: 36129020
[TBL] [Abstract][Full Text] [Related]
27. Interaction gene set between osteoclasts and regulatory CD4
Li F; Tang H; Luo X; Li X; Luo K; Liu S; Liang J; Liao S; Zhong C; Zhan X; Wei Q; Feng W; Liu Y
Cancer Sci; 2023 Jul; 114(7):3014-3026. PubMed ID: 37150900
[TBL] [Abstract][Full Text] [Related]
28. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
29. Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma.
Yang J; Zhang A; Luo H; Ma C
Sci Rep; 2022 Jan; 12(1):1279. PubMed ID: 35075228
[TBL] [Abstract][Full Text] [Related]
30. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
31. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Lei T; Qian H; Lei P; Hu Y
Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
[TBL] [Abstract][Full Text] [Related]
32. Identification of two immune subtypes in osteosarcoma based on immune gene sets.
Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z
Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161
[TBL] [Abstract][Full Text] [Related]
33. Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways.
Wu C; Tan J; Shen H; Deng C; Kleber C; Osterhoff G; Schopow N
J Biomed Sci; 2024 Jan; 31(1):4. PubMed ID: 38212768
[TBL] [Abstract][Full Text] [Related]
34. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
Guo J; Li X; Shen S; Wu X
Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
[TBL] [Abstract][Full Text] [Related]
36. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
Xu F; Yan J; Peng Z; Liu J; Li Z
Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
[TBL] [Abstract][Full Text] [Related]
38. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
39. Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.
Liu W; Xia K; Zheng D; Huang X; Wei Z; Wei Z; Guo W
BMC Cancer; 2023 Dec; 23(1):1179. PubMed ID: 38041020
[TBL] [Abstract][Full Text] [Related]
40. A CIC-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma.
Yu B; Geng C; Wu Z; Zhang Z; Zhang A; Yang Z; Huang J; Xiong Y; Yang H; Chen Z
Sci Rep; 2024 Jan; 14(1):1308. PubMed ID: 38225273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]